Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE   2014 , Volume 5 , Number 1; Page(s) 7 To 14.
 
Paper: 

DIFFERENCES IN MEDICATION ADHERENCE BETWEEN LIVING AND DECEASED DONOR KIDNEY TRANSPLANT PATIENTS

 
 
Author(s):  DENHAERYNCK K., SCHMID MOHLER G., KISS A., STEIGER J., WUTHRICH R.P., BOCK A., DE GEEST S.*
 
* CENTER OF HEALTH SERVICES AND NURSING RESEARCH, K.U. LEUVEN, LEUVEN, BELGIUM RN, INSTITUTE OF NURSING SCIENCE, UNIVERSITY OF BASEL, BERNOULLISTRASSE 28, CH-4056 BASEL, SWITZERLAND
 
Abstract: 
Background: Literature review suggests that adherence to immunosuppressive drugs may be lower in recipients of living than of deceased donor kidney grafts, possibly because of profile differences.Objective: To compare the level of immunosuppressive adherence levels between patients with deceased and living (-related;-unrelated) donor grafts in Switzerland.Methods: Using data from two similar cross-sectional studies at two transplant centers in Switzerland, the level of adherence between the two groups was compared. Medication adherence was assessed by self-report or electronic monitoring. Possible explanatory factors included age, beliefs regarding immunosuppressive drugs, depressive symptomatology, pre-emptive transplantation, and the number of transplants received, were also considered. Data were analyzed using logistic regression analysis.Results: Unadjusted non-adherence odds were 2 to 3 times higher in living-related than deceased donor transplantation (ORs: 2.09-3.05; p<0.05). Adjustment for confounders showed that these differences were associated most with the younger age of living-related subjects and the belief that immunosuppressive drugs are less important for living-related donations.Conclusion: There is a lower immunosuppressive adherence in recipients of living-related donor kidneys, possibly owing to differences in patient profile (ie, health beliefs regarding their immunosuppressive needs), knowledge of which may enhance adherence if addressed.
 
Keyword(s): LIVING RELATED TRANSPLANTATION, IMMUNOSUPPRESSANT ADHERENCE, KIDNEY TRANSPLANTATION, DONOR, GRAFT
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

DENHAERYNCK, K., & SCHMID MOHLER, G., & KISS, A., & STEIGER, J., & WUTHRICH, R., & BOCK, A., & DE GEEST, S. (2014). DIFFERENCES IN MEDICATION ADHERENCE BETWEEN LIVING AND DECEASED DONOR KIDNEY TRANSPLANT PATIENTS. INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, 5(1), 7-14. https://www.sid.ir/en/journal/ViewPaper.aspx?id=410798



Vancouver: Copy

DENHAERYNCK K., SCHMID MOHLER G., KISS A., STEIGER J., WUTHRICH R.P., BOCK A., DE GEEST S.. DIFFERENCES IN MEDICATION ADHERENCE BETWEEN LIVING AND DECEASED DONOR KIDNEY TRANSPLANT PATIENTS. INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE. 2014 [cited 2021December03];5(1):7-14. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=410798



IEEE: Copy

DENHAERYNCK, K., SCHMID MOHLER, G., KISS, A., STEIGER, J., WUTHRICH, R., BOCK, A., DE GEEST, S., 2014. DIFFERENCES IN MEDICATION ADHERENCE BETWEEN LIVING AND DECEASED DONOR KIDNEY TRANSPLANT PATIENTS. INTERNATIONAL JOURNAL OF ORGAN TRANSPLANTATION MEDICINE, [online] 5(1), pp.7-14. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=410798.



 
  pdf-File
Yearly Visit 43
 
 
Latest on Blog
Enter SID Blog